Oxyquinoline toxicity.
D007464:Clioquinol / Q000009:adverse effects*; D004240:Diverticulum / Q000188:drug therapy; D004338:Drug Combinations / Q000627:therapeutic use; D005602:France; D006801:Humans; D006912:Hydroxyquinolines / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009187:Myelitis / Q000139:chemically induced; D009902:Optic Neuritis / Q000139:chemically induced*; D015125:Oxyquinoline / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000627:therapeutic use; D013577:Syndrome
D004338:Drug Combinations; D006912:Hydroxyquinolines; D015125:Oxyquinoline; D007464:Clioquinol; C032033:5-methyl-8-hydroxyquinoline; C037666:intetrix; C037665:tilbroquinol